Shenzhen Edge Medical Co., Ltd. (HKG:2675)
Hong Kong
· Delayed Price · Currency is HKD
61.05
-3.05 (-4.76%)
At close: Mar 9, 2026
Shenzhen Edge Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 279.13 | 159.99 | 48.04 |
| Revenue Growth (YoY) | - | 233.03% | - |
| Cost of Revenue | 125.48 | 81.03 | 43.48 |
| Gross Profit | 153.65 | 78.96 | 4.56 |
| Selling, General & Admin | 157.33 | 134.72 | 100.23 |
| Research & Development | 227.19 | 226.25 | 171.23 |
| Operating Expenses | 388.76 | 362 | 272.01 |
| Operating Income | -235.11 | -283.04 | -267.44 |
| Interest Expense | -0.7 | -0.86 | -0.99 |
| Interest & Investment Income | 5.94 | 5.22 | 5.36 |
| Currency Exchange Gain (Loss) | -0.37 | -0.12 | 0.18 |
| Other Non Operating Income (Expenses) | 31.2 | 30.71 | 3 |
| EBT Excluding Unusual Items | -199.11 | -248.09 | -259.89 |
| Gain (Loss) on Sale of Investments | 25.53 | 31.02 | 47.02 |
| Asset Writedown | -1.43 | -1.43 | - |
| Pretax Income | -175.01 | -218.51 | -212.87 |
| Net Income | -175.03 | -218.51 | -212.87 |
| Net Income to Common | -175.03 | -218.51 | -212.87 |
| Shares Outstanding (Basic) | 360 | 360 | 360 |
| Shares Outstanding (Diluted) | 360 | 360 | 360 |
| EPS (Basic) | -0.49 | -0.61 | -0.59 |
| EPS (Diluted) | -0.49 | -0.61 | -0.59 |
| Free Cash Flow | -192.01 | -251.03 | -381.64 |
| Free Cash Flow Per Share | -0.53 | -0.70 | -1.06 |
| Gross Margin | 55.05% | 49.35% | 9.49% |
| Operating Margin | -84.23% | -176.91% | -556.69% |
| Profit Margin | -62.70% | -136.57% | -443.09% |
| Free Cash Flow Margin | -68.79% | -156.90% | -794.39% |
| EBITDA | -215.67 | -264.82 | -259.09 |
| EBITDA Margin | -77.26% | -165.52% | - |
| D&A For EBITDA | 19.44 | 18.22 | 8.36 |
| EBIT | -235.11 | -283.04 | -267.44 |
| EBIT Margin | -84.23% | -176.91% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.